BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2443930)

  • 1. Progress toward the understanding of the molecular mechanisms of interferon action.
    Samuel CE
    Prog Clin Biol Res; 1987; 246():209-20. PubMed ID: 2443930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferons, interferon-like cytokines, and their receptors.
    Pestka S; Krause CD; Walter MR
    Immunol Rev; 2004 Dec; 202():8-32. PubMed ID: 15546383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
    Schaber JD; Fang H; Xu J; Grimley PM; Rui H
    Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of class II MHC gene expression by interferons: insights into the mechanism of action of interferon (review).
    Giacomini P; Fisher PB; Duigou GJ; Gambari R; Natali PG
    Anticancer Res; 1988; 8(6):1153-61. PubMed ID: 2464333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of functional type I and type II interferon receptors.
    Pestka S
    Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1301-19. PubMed ID: 7705745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interferon and diseases].
    Kita M
    Rinsho Byori; 1994 Aug; 42(8):860-6. PubMed ID: 7523746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A large component of the antiviral activity of mouse interferon-gamma may be due to its induction of interferon-alpha.
    Hughes TK; Baron S
    J Biol Regul Homeost Agents; 1987; 1(1):29-32. PubMed ID: 3142215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genes of interferons and interferon-related factors: localization and relationships with chromosome aberrations in cancer.
    Haus O
    Arch Immunol Ther Exp (Warsz); 2000; 48(2):95-100. PubMed ID: 10807049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activity of CHO-SS cell-derived human omega interferon and other human interferons against HCV RNA replicons and related viruses.
    Buckwold VE; Wei J; Huang Z; Huang C; Nalca A; Wells J; Russell J; Collins B; Ptak R; Lang W; Scribner C; Blanchett D; Alessi T; Langecker P
    Antiviral Res; 2007 Feb; 73(2):118-25. PubMed ID: 16987555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human interferons alpha, beta and omega.
    Bekisz J; Schmeisser H; Hernandez J; Goldman ND; Zoon KC
    Growth Factors; 2004 Dec; 22(4):243-51. PubMed ID: 15621727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dominant negative mutant of an IFN regulatory factor family protein inhibits both type I and type II IFN-stimulated gene expression and antiproliferative activity of IFNs.
    Thornton AM; Ogryzko VV; Dent A; Sharf R; Levi BZ; Kanno Y; Staudt LM; Howard BH; Ozato K
    J Immunol; 1996 Dec; 157(11):5145-54. PubMed ID: 8943426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses.
    Zimmermann A; Trilling M; Wagner M; Wilborn M; Bubic I; Jonjic S; Koszinowski U; Hengel H
    J Exp Med; 2005 May; 201(10):1543-53. PubMed ID: 15883169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I interferon subtypes produced by human peripheral mononuclear cells from one normal donor stimulated by viral and non-viral inducing factors.
    Palmer P; Tovey MG; Raschilas F; Brassart L; Meritet JF; Porcher R; Lebon P
    Eur Cytokine Netw; 2007 Jun; 18(2):108-14. PubMed ID: 17594944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
    Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
    Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the interferon system, immune response and oncogenesis by the transcription factor interferon regulatory factor-1.
    Taniguchi T; Tanaka N; Taki S
    Eur Cytokine Netw; 1998 Sep; 9(3 Suppl):43-8. PubMed ID: 9831185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic activities of natural and synthetic type I interferons.
    Pfeffer LM
    Semin Oncol; 1997 Jun; 24(3 Suppl 9):S9-63-S9-69. PubMed ID: 9208874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody to staphylococcal enterotoxin A-induced human immune interferon (IFN gamma).
    Langford MP; Weigent DA; Georgiades JA; Johnson HM; Stanton GJ
    J Immunol; 1981 Apr; 126(4):1620-3. PubMed ID: 6162895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin alpha 11 is a novel type I interferon stimulated gene.
    Leomil Coelho LF; Mota BE; Sales PC; Marques JT; de Oliveira JG; Bonjardim CA; Peregrino Ferreira PC; Kroon EG
    Cytokine; 2006 Mar; 33(6):352-61. PubMed ID: 16697656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of C1-inhibitor synthesis by interferons and other agents.
    Lappin D; Whaley K
    Behring Inst Mitt; 1989 Jul; (84):180-92. PubMed ID: 2478116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.